Insider · CIK 0001040766

COLONNESE MARK P

Reports to the SEC for 5 companies · ALPHARETTA, GA

sec.gov

Transactions

Companies

Filings

CIK

0001040766

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-03-28	BPTHBIO-PATH HOLDINGS, INC. · Common Stock Option (right to buy)A Award	Director	AAward	+1,000 sh	—	—	1,000
2018-04-17	BPTHBIO-PATH HOLDINGS, INC. · Common Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-07-13	BPTHBIO-PATH HOLDINGS, INC. · Common Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-04-03	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+400K sh	$0.66	+$262K	775,000
2016-07-27	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	$1.34	+$201K	375,000
2016-02-09	VXRTVaxart, Inc.P Purchase	Chief Financial Officer	PPurchase	+6,700 sh	$1.41	+$9,427.57	7,000
2016-02-09	VXRTVaxart, Inc.P Purchase	Chief Financial Officer	PPurchase	+300 sh	$1.40	+$419.01	300
2015-11-02	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+225K sh	$2.02	+$455K	225,000
2014-02-18	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+7,000 sh	—	—	7,000
2014-02-18	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+7,000 sh	—	—	7,000
2014-02-18	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+7,000 sh	—	—	7,000
2013-09-30	PRPOPrecipio, Inc. · Stock Appreciation RightsA Award	Chief Financial Officer	AAward	+660K sh	—	—	660,000
2013-09-30	PRPOPrecipio, Inc. · Stock Appreciation RightsA Award	Chief Financial Officer	AAward	+690K sh	—	—	690,000
2013-05-03	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+66.7K sh	—	—	66,667
2013-05-03	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+66.7K sh	—	—	66,667
2013-05-03	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+66.7K sh	—	—	66,666
2012-09-12	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+83.3K sh	—	—	83,333
2012-09-12	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+83.3K sh	—	—	83,334
2012-09-12	PRPOPrecipio, Inc. · Purchase OptionA Award	Chief Financial Officer	AAward	+83.3K sh	—	—	83,333
2008-09-25	ATHEROGENICS INCG Gift	VP Commercial Operations & CFO	GGift	−25K sh	—	—	0
2007-06-19	ATHEROGENICS INCNon-qualified stock option (right to buy)A Award	VP Commercial Operations & CFO	AAward	+65.7K sh	—	—	65,728
2006-05-31	ATHEROGENICS INCNon-qualified stock option (right to buy)A Award	VP Commercial Operations & CFO	AAward	+12K sh	—	—	12,000
2005-02-24	ATHEROGENICS INCS Sale	VP Commercial Operations & CFO	SSale	−39.4K sh	$17.51	−$690K	0
2004-12-31	ATHEROGENICS INCIncentive Stock Option (Right to buy)A Award	VP Commercial Operations & CFO	AAward	+60K sh	—	—	60,000
2003-12-31	ATHEROGENICS INCIncentive Stock Option (Right to Buy)A Award	VP Commercial Operations & CFO	AAward	+57K sh	—	—	57,000
2003-11-18	ATHEROGENICS INCS Sale	VP Commercial Operations & CFO	SSale	−30K sh	$15.16	−$455K	39,400
2003-11-18	ATHEROGENICS INCS Sale	VP Commercial Operations & CFO	SSale	−30K sh	$15.16	−$455K	39,400
1997-05-08	AAIPHARMA INCS Sale	Insider	SSale	−22K sh	$18.25	−$402K	0
1997-05-08	AAIPHARMA INCM Exercise/Conversion	Insider	MExercise/Conversion	+22K sh	$8.35	+$184K	—
1997-05-01	AAIPHARMA INCEMPLOYEE STOCK OPTIONA Award	Insider	AAward	+5,000 sh	—	—	—

Recent filings

Accepted (ET)
Apr 14
COLONNESE MARK P0001007382-19-000005
SEC(opens sec.gov)
Apr 194
COLONNESE MARK P0001599765-18-000003
SEC(opens sec.gov)
Jul 174
COLONNESE MARK P0001603963-17-000003
SEC(opens sec.gov)
Apr 54
Aviragen Therapeutics, Inc.0001437749-17-006118
SEC(opens sec.gov)
Jul 294
Aviragen Therapeutics, Inc.0001140361-16-073916
SEC(opens sec.gov)
Feb 94
Biota Pharmaceuticals, Inc.0001437749-16-025031
SEC(opens sec.gov)
Nov 34
Biota Pharmaceuticals, Inc.0001437749-15-019484
SEC(opens sec.gov)
Feb 204
TRANSGENOMIC INC0001144204-14-010773
SEC(opens sec.gov)
Oct 74/A
TRANSGENOMIC INC0001144204-13-054323
SEC(opens sec.gov)
Oct 34
TRANSGENOMIC INC0001144204-13-053863
SEC(opens sec.gov)
May 74
TRANSGENOMIC INC0001144204-13-026768
SEC(opens sec.gov)
Sep 174
TRANSGENOMIC INC0001144204-12-051753
SEC(opens sec.gov)
Feb 55
ATHEROGENICS INC0001107601-09-000005
SEC(opens sec.gov)

Companies

Address

8995 WESTSIDE PARKWAY

ALPHARETTA, GA, 30004